Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193805-25-001522
Filing Date
2025-10-30
Accepted
2025-10-29 17:35:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 e664935_424b3-novabridge.htm 424B3 142579
3 GRAPHIC logo.jpg GRAPHIC 9864
4 GRAPHIC image.jpg GRAPHIC 11940
  Complete submission text file 0001193805-25-001522.txt   173945
Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850
Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800
NovaBridge Biosciences (Filer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-289158 | Film No.: 251431239
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)